Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement

ARQT•2026-07-17

Initial Form 3 filing

Arcutis Biotherapeutics director Christopher Peetz filed an initial Form 3 reporting 187,500 common shares held indirectly through The Peetz Family Trust.

Sources

Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement

Sec

Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement

Initial Form 3 filing

Related News

Nasdaq trade halt continues <PLTS.O> reason not available at 03:28 AM

Nasdaq Trade Halt Continues <ELPW.O> Halt News Pending at 03:28 AM

Berkshire Hathaway Says 66% Of Aggregate Fair Value Of Equity Investments Was Concentrated In American Express, Apple, Bank Of America, Alphabet & Coca-Cola As Of June 30

Sources

Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement

Nasdaq trade halt continues <SXTC.O> halt news pending at 03:28 AM

Delta flight makes emergency landing in Atlanta